Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Raciborz

9 clinical trials in Raciborz, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Raciborz at a glance
9
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Raciborz

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Raciborz

What the registry says about research in the country

01 Lung Cancer Research

Innovative clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, particularly investigating new combination therapies and targeted approaches.

  • Metastatic NSCLC treatments
  • Post-surgery cancer prevention
  • Advanced NSCLC therapies

Studies evaluating various therapeutic combinations including pembrolizumab and novel targeted agents for improving patient outcomes.

02 Cardiovascular Studies

Research examining innovative treatments for acute coronary syndrome, with a focus on exploring new applications of established medications.

  • Coronary intervention outcomes
  • Preventive therapies
  • Post-PCI treatment optimization

Investigations into reducing the need for repeated coronary procedures through metabolic intervention approaches.

03 Breast Cancer Innovations

Advanced research targeting hormone receptor-positive breast cancer, focusing on extended therapy approaches for early-stage disease.

  • Extended endocrine therapy
  • Recurrence prevention
  • Targeted therapeutic approaches

Studies evaluating novel therapeutic agents for improving long-term outcomes in breast cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.